Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Mental Disability Clinical Trials

A listing of Mental Disability medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (48) clinical trials

Study for Pediatric ADHD Learning that your 4 or 5 year old child has attention-deficit/hyperactivity disorder (ADHD) is challenging. It may leave you wondering what options are available for your child and whether they will be safe for your child at such a young age. New clinical research studies will ...

Phase N/A

Study for Pediatric ADHD Learning that your [4 to 12] [4 or 5] year old child has attention-deficit/hyperactivity disorder (ADHD) is challenging. It may leave you wondering what options are available for your child and whether they will be safe for your child at such a young age. New clinical ...

Phase N/A

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophrenia

Phase

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophre

Phase

A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia

Phase

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophrenia

Phase

Interventional, randomized, double-blind, active-controlled, fixed-dose study of Lu AF35700 in patients with treatment-resistant schizophrenia

Phase

A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole (1-3 mg/day) as Monotherapy or as Combination Therapy in the Treatment of Adults with Post-traumatic Stress Disorder

Phase

A Randomized, Open-label, Multiple-dose, Parallel Design, Comparative Bioequivalence Study of Paliperidone Palmitate Extended-Release Injectable Suspension (156 mg/1.0 mL) Versus Invega Sustenna® (paliperidone palmitate) Extended-Release Injectable Suspension (156mg/1.0 mL) in Schizophrenia Patients Already Stabilized on Paliperidone Palmitate

Phase N/A

The purpose of this study is to better understand symptoms in psychiatric disorders, such as difficulties with memory, thinking, and motivation and how they impact daily life and functioning.  

Phase N/A